NASDAQ:AVGR - Avinger Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Avinger Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.65 -0.02 (-2.99 %) (As of 02/24/2020 11:32 AM ET) Add Compare Today's Range$0.63Now: $0.65▼$0.6550-Day Range$0.60MA: $0.88▼$1.2552-Week Range$0.59Now: $0.65▼$12.60Volume1,405 shsAverage Volume569,784 shsMarket Capitalization$10.91 millionP/E RatioN/ADividend YieldN/ABeta1.75 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:AVGR Previous Symbol CUSIPN/A CIK1506928 Webhttp://www.avinger.com/ Phone650-241-7900Debt Debt-to-Equity Ratio0.50 Current Ratio1.37 Quick Ratio1.09Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$7.91 million Price / Sales1.38 Cash FlowN/A Price / Cash FlowN/A Book Value$2.71 per share Price / Book0.24Profitability EPS (Most Recent Fiscal Year)($33.40) Net Income$-27,560,000.00 Net Margins-237.51% Return on Equity-197.22% Return on Assets-76.49%Miscellaneous EmployeesN/A Outstanding Shares16,790,000Market Cap$10.91 million Next Earnings Date3/4/2020 (Estimated) OptionableNot Optionable Receive AVGR News and Ratings via Email Sign-up to receive the latest news and ratings for AVGR and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:AVGR Rates by TradingView Avinger (NASDAQ:AVGR) Frequently Asked Questions What is Avinger's stock symbol? Avinger trades on the NASDAQ under the ticker symbol "AVGR." When did Avinger's stock split? How did Avinger's stock split work? Avinger shares reverse split on the morning of Wednesday, January 31st 2018. The 1-40 reverse split was announced on Tuesday, January 30th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, January 30th 2018. An investor that had 100 shares of Avinger stock prior to the reverse split would have 3 shares after the split. How were Avinger's earnings last quarter? Avinger Inc (NASDAQ:AVGR) posted its quarterly earnings results on Tuesday, November, 5th. The medical device company reported ($0.70) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.60) by $0.10. The medical device company earned $2.41 million during the quarter. Avinger had a negative net margin of 237.51% and a negative return on equity of 197.22%. View Avinger's Earnings History. When is Avinger's next earnings date? Avinger is scheduled to release their next quarterly earnings announcement on Wednesday, March 4th 2020. View Earnings Estimates for Avinger. What is the consensus analysts' recommendation for Avinger? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avinger in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Avinger. Has Avinger been receiving favorable news coverage? Media stories about AVGR stock have been trending negative this week, according to InfoTrie. The research group ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Avinger earned a coverage optimism score of -2.1 on InfoTrie's scale. They also assigned news articles about the medical device company a news buzz of 2.0 out of 10, meaning that recent media coverage is very unlikely to have an effect on the stock's share price in the near term. View News Stories for Avinger. Who are some of Avinger's key competitors? Some companies that are related to Avinger include T2 Biosystems (TTOO), Delcath Systems (DCTH), Invo Bioscience (IVOB), Arch Therapeutics (ARTH), Interpace Diagnostics Group (IDXG), Neovasc (NVCN), Biostage (BSTG), RA Medical Systems (RMED), DarioHealth (DRIO), Titan Medical (TMDI), Endologix (ELGX), Obalon Therapeutics (OBLN), Hancock Jaffe Laboratories (HJLI), Atossa Genetics (ATOS) and Dynatronics (DYNT). What other stocks do shareholders of Avinger own? Based on aggregate information from My MarketBeat watchlists, some companies that other Avinger investors own include AcelRx Pharmaceuticals (ACRX), Palatin Technologies (PTN), SCYNEXIS (SCYX), AVEO Pharmaceuticals (AVEO), Trevena (TRVN), Actinium Pharmaceuticals (ATNM), Aralez Pharmaceuticals (ARLZ), Biocept (BIOC), Bellerophon Therapeutics (BLPH) and Micron Technology (MU). Who are Avinger's key executives? Avinger's management team includes the folowing people: Mr. Jeffrey M. Soinski, Pres, CEO & Director (Age 57)Mr. Mark B. Weinswig, Chief Financial Officer (Age 46)Mr. Himanshu N. Patel, Chief Technology Officer (Age 59)Mr. Keith Schaefer, Chief Operating OfficerMr. Philip R. Preuss, VP of Marketing & Bus. Operations (Age 41) When did Avinger IPO? (AVGR) raised $60 million in an initial public offering on Friday, January 30th 2015. The company issued 4,600,000 shares at $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company served as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers. Who are Avinger's major shareholders? Avinger's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Perkins Capital Management Inc. (6.86%). View Institutional Ownership Trends for Avinger. Which institutional investors are selling Avinger stock? AVGR stock was sold by a variety of institutional investors in the last quarter, including Perkins Capital Management Inc.. View Insider Buying and Selling for Avinger. How do I buy shares of Avinger? Shares of AVGR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Avinger's stock price today? One share of AVGR stock can currently be purchased for approximately $0.65. How big of a company is Avinger? Avinger has a market capitalization of $10.91 million and generates $7.91 million in revenue each year. The medical device company earns $-27,560,000.00 in net income (profit) each year or ($33.40) on an earnings per share basis. View Additional Information About Avinger. What is Avinger's official website? The official website for Avinger is http://www.avinger.com/. How can I contact Avinger? Avinger's mailing address is 400 CHESAPEAKE DRIVE, REDWOOD CITY CA, 94063. The medical device company can be reached via phone at 650-241-7900 or via email at [email protected] MarketBeat Community Rating for Avinger (NASDAQ AVGR)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 347 (Vote Outperform)Underperform Votes: 307 (Vote Underperform)Total Votes: 654MarketBeat's community ratings are surveys of what our community members think about Avinger and other stocks. Vote "Outperform" if you believe AVGR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AVGR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/24/2020 by MarketBeat.com StaffFeatured Article: Correction
